Rhabdomyolysis with simvastatin

Patel, Brijesh R; Choudhury, M.

doi:10.1136/bcr.12.2009.2552

Cited by 3 publications

(1 citation statement)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prognosis is usually excellent if the underlying mechanism of rhabdomyolysis can be identified and reversed, whenever it is possible. After 3-30 days of withdrawal of statins the muscular symptoms usually decrease, and the CPK normalizes [8]. …”

Section: Discussionmentioning

confidence: 99%

Acute Kidney Injury and Quadriparesis Due to Rosuvastatin Induced Rhabdomyolysis- A Case Report

Suthar¹,

Vanikar²,

Trivedi

2015

JCDR

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Acute Kidney Injury and Quadriparesis Due to Rosuvastatin Induced Rhabdomyolysis- A Case Report

Suthar¹,

Vanikar²,

Trivedi

2015

JCDR

View full text Add to dashboard Cite

Evaluation of <i>Lactobacillus acidophilus</i> and <i>Bacillus coagulans</i> against Simvastatin-induced Rhabdomyolysis in Hypercholesterolemic Rats

Dilip Raja,

Kumari,

Rani

2024

JNR

View full text Add to dashboard Cite

Background: This study investigates the possible synergistic influence of probiotics, specifically Lactobacillus acidophilus (LA) and Bacillus coagulans (BC), in conjunction with Simvastatin (SMV) for treating Rhabdomyolysis in hypercholesteremic rats. Aim: The study aims to evaluate the combined effects of SMV with LA or BC on various health parameters in hypercholesteremic rats induced with rhabdomyolysis. Methods: Hypercholesteremic rats with rhabdomyolysis were treated with SMV, LA, BC, and combinations of SMV with LA or BC. The study measured body weight, lipid profiles, renal function, skeletal muscle, and inflammation markers. Results: The combination treatments showed promise in reducing body weight gain. Regarding lipid profiles, SMV in tandem with LA demonstrated slightly enhanced efficacy in lipid regulation compared to other combinations. Both probiotic strains exhibited substantial potential in preserving nephron function alongside SMV. Probiotic combinations with SMV helped mitigate skeletal muscle dysfunction. Regarding inflammation, both combinations alleviated inflammation symptomatic of rhabdomyolysis. Notably, BC, combined with SMV, excelled in dampening inflammatory cytokines like TNF-α and IL-6, surpassing LA. Conclusion: The combined administration of SMV with LA or BC effectively mitigates rhabdomyolysis-induced issues, with varying impacts on diverse outcomes. Future investigations are imperative to comprehensively ascertain the optimal probiotic regimen for managing rhabdomyolysis. These positive outcomes underscore the multifaceted roles of probiotics in addressing rhabdomyolysis-related complications, emphasizing the necessity for further exploration into their mechanisms and clinical implications.

show abstract

The current system for prescribing antiretroviral therapy puts HIV-infected patients at risk of serious drug-drug interactions: is now the time for a paradigm shift in HIV care delivery?

et al. 2012

View full text Add to dashboard Cite

Rhabdomyolysis with simvastatin

Cited by 3 publications

References 34 publications

Acute Kidney Injury and Quadriparesis Due to Rosuvastatin Induced Rhabdomyolysis- A Case Report

Acute Kidney Injury and Quadriparesis Due to Rosuvastatin Induced Rhabdomyolysis- A Case Report

Evaluation of <i>Lactobacillus acidophilus</i> and <i>Bacillus coagulans</i> against Simvastatin-induced Rhabdomyolysis in Hypercholesterolemic Rats

The current system for prescribing antiretroviral therapy puts HIV-infected patients at risk of serious drug-drug interactions: is now the time for a paradigm shift in HIV care delivery?

Contact Info

Product

Resources

About